California Personal Injury Law Firm
With locations throughout California, we have the resources and experience to take on any corporate opponent and win.
You Won't Pay Unless We Win
Wisner Baum offers free case evaluations. If our injury attorneys do not obtain compensation on your behalf, you owe us nothing.
Over $4 Billion Won For Our Clients
Our history of success reflects our relentless pursuit of justice and unwavering dedication to achieving the best possible outcome for every case we handle.
Since 1985, Wisner Baum has established itself as a leading pharmaceutical litigation firm with a track record of success holding Big Pharma accountable. Based in Los Angeles, California, our team of experienced pharmaceutical attorneys fights on behalf of people nationwide who have been harmed by major corporations that prioritize profits over patient safety.
Our proven track record in pharmaceutical litigation includes:
If you or someone in your family has suffered serious injuries or complications from a prescription medication, our pharmaceutical lawyers can help you pursue the compensation you deserve. We work on contingency, which means if we don’t win, you don’t pay.
Contact us today for a free case evaluation.
We have extensive experience litigating drug injury, wrongful death, and consumer class action cases against major pharmaceutical corporations. Our prescription drug attorneys have been at the forefront of pharmaceutical litigation for decades, achieving significant results for our clients.
Our track record in prescription drug litigation includes:
Our pharmaceutical lawyers understand the complex medical and scientific issues involved in prescription drug lawsuits. Wisner Baum has the necessary resources and extensive experience to take on the largest pharmaceutical corporations and achieve successful outcomes.
Prescription medications are meant to improve health conditions and quality of life. But even with FDA approval, it is not uncommon for drugs to cause serious side effects. The consequences of defective drugs can be devastating, ranging from severe health complications to permanent disability or death.
Pharmaceutical litigation is important not only to compensate those harmed by these products, but also to hold drug makers accountable for failing to adequately test products or warn of known or reasonably knowable risks.
A pharmaceutical injury lawsuit typically involves:
For injured patients, a pharmaceutical lawsuit can help pay for medical bills, lost wages, and the pain experienced after taking the medication or receiving a procedure using a defective medical device. Beyond helping individual plaintiffs, pharmaceutical lawsuits help protect all consumers by pushing companies to be honest about their products. These cases often reveal that companies were aware of certain dangers but concealed them to continue generating profits.
When pharmaceutical lawsuits are successful, they not only compensate victims but also compel drug manufacturers to enhance safety standards, update warning labels, and sometimes even remove defective products from the market altogether.
Pharmaceutical drug lawsuits happen when the products cause unexpected harm and the companies that manufacture the products failed to warn about the potential harm. These lawsuits aim to compensate those harmed and hold companies accountable for their negligence or wrongdoing.
To qualify for a drug injury lawsuit, you must have suffered verifiable harm after taking the medication or undergoing a procedure using a defective device. Your lawyer will need to show a clear connection between taking the drug or undergoing a procedure and your injury or side effects.
Most of the time, these lawsuits are consolidated into a mass tort, which is similar to a class action in that many people harmed by the same product join together in front of one judge. The key difference between a mass tort and a class action is that each person's specific injuries and claims for damages differ in a mass tort, so each plaintiff is treated individually. In a class action, the group (“class”) is treated as a single entity with a representative plaintiff (or plaintiffs).
The legal process for prescription drug lawsuits typically takes one to three years, although it can be longer or shorter depending on your case.
Every state has a deadline called a "statute of limitations" for filing these lawsuits, ranging from one to six years after you discover your injury. If you miss this deadline, you may lose your right to seek compensation, so it is crucial to speak to a lawyer as soon as you can about your potential claim.
If you've been harmed by a prescription or over-the-counter medication, an experienced pharmaceutical lawyer can be your strongest advocate.
Our attorneys will:
At Wisner Baum, our California pharmaceutical lawyers handle cases on a contingency fee basis, meaning you pay nothing unless we win your case. This allows anyone harmed by defective drugs to access quality legal representation regardless of their financial situation.
Our pharmaceutical litigation attorneys are currently investigating and accepting cases involving several medications. If any of the following drugs have harmed you, our law firm can help determine if you have a viable claim.
Risperdal (risperidone), Invega (paliperidone), and Zyprexa (olanzapine) are antipsychotic medications linked to an increased risk of breast cancer. Our pharmaceutical lawyers were the first in the country to file a lawsuit alleging Johnson & Johnson and Eli Lilly failed to warn patients and the medical community about the link between antipsychotics and breast cancer, which we allege the companies knew since the 1990s.
Learn more about Antipsychotics and Breast Cancer Lawsuits
Zantac (ranitidine) was a widely used heartburn medication that was found to contain N-nitrosodimethylamine (NDMA), a probable human carcinogen. In 2020, the FDA requested a market withdrawal for Zantac due to these concerns. Our pharmaceutical attorneys are helping individuals who developed cancer after taking Zantac for extended periods.
Learn more about Zantac Cancer Lawsuits
Ozempic (semaglutide) is a popular diabetes and weight loss medication that has been linked to serious adverse effects, including pancreatitis, gallbladder disease, and severe gastrointestinal issues. Our pharmaceutical attorneys are investigating claims for affected patients.
Learn more about Ozempic Lawsuits
Suboxone (buprenorphine/naloxone) is used to treat opioid dependence. It is associated with serious side effects and allegations of anticompetitive practices by its manufacturer. Our law firm represents individuals harmed by this medication.
Learn more about Suboxone Lawsuits
When you work with our California pharmaceutical attorneys, we handle every aspect of your case from start to finish:
The process begins with a free, confidential consultation where our lawyers will review your medical history, drug usage, and resulting injuries to determine if you have a viable claim. We will explain your legal options and what to expect throughout the legal process.
Our pharmaceutical attorneys will collect comprehensive evidence to support your case, including:
Our pharmaceutical lawyers will prepare and file a detailed complaint in the appropriate jurisdiction, whether in state court, federal court, or as part of multidistrict litigation (MDL). The complaint will outline your injuries, the defendant's alleged liability, and the compensation you are seeking.
During discovery, both sides exchange information and evidence. Our pharmaceutical attorneys will depose key witnesses, including company executives and medical experts. We also review internal company documents to determine whether the company engaged in any misconduct related to your claim, and to build the strongest possible case. Our firm is known for getting confidential company documents “unsealed” and publishing important “smoking gun” documents that are important to public health and safety.
Many cases resolve through settlement negotiations. Our law firm will advocate for maximum compensation that fully accounts for your medical expenses, lost income, pain and suffering, and other damages. We will advise you of the strength of any settlement offer, but the final decision to accept remains yours.
If a fair settlement cannot be reached, our pharmaceutical attorneys are fully prepared to take your case to trial. We have extensive courtroom experience and will present compelling evidence and testimony to demonstrate the pharmaceutical company's liability and the extent of your damages.
Each state has a deadline for filing a drug injury lawsuit. In California, the statute of limitations for filing a pharmaceutical lawsuit is generally:
For cases outside California, different timeframes may apply. Additionally, the statute of limitations may be extended through various legal doctrines, including:
To protect your legal rights, it is crucial to consult with a defective drug lawyer as soon as possible after discovering an injury. Our pharmaceutical attorneys can help determine the applicable deadlines in your specific case.
Wisner Baum’s track record of success in pharmaceutical litigation dates back to the 1980s. Our pharmaceutical attorneys have not only won landmark cases against Big Pharma; we have also spearheaded and participated in numerous campaigns to address and correct industry practices that caused our clients to suffer harm. While our efforts may not directly have impacted our casework, we have always fought—and will continue to fight—for safety improvements that have the potential to prevent similar harm from happening in the future.
As managing partner, R. Brent Wisner said in an interview with Super Lawyers Magazine:
"We get these really incredible documents that affect people's public health, and we make a point to get them unsealed. Most lawyers don't bother or care to do that because it doesn't really affect the case; but for us it's a greater good kind of thing."
Lawsuits were filed against Zoloft-maker, Pfizer in the early 2000s alleging the drug caused an increased risk of suicidal behavior, and in the late 2000s, a lawsuit was filed claiming the manufacturer overpromoted the drug’s efficacy.
Internal documents showed Pfizer was aware of Zoloft’s questionable efficacy in treating depression and that the FDA approved the drug despite its efficacy shortcomings only because the FDA’s standard for approving antidepressants is “not as demanding as it ought to be.”
GlaxoSmithKline (GSK) faced hundreds of lawsuits alleging Paxil could induce suicidal behavior in both adults and children/adolescents.
Unsealed internal documents obtained in the litigation showed the Paxil pediatric clinical trials all failed to outperform placebo on primary efficacy measures and that the drug posed a suicidal behavior risk (which GSK misleadingly coded as “emotional lability”) to young people. Nonetheless, the company promoted Paxil as efficacious and denied any suicide risk, using Key Opinion Leaders (KOLs) and ghostwriting positive medical journal articles, contrary to the underlying data.
Documents also showed the company was aware that adult patients given Paxil during clinical trials experienced suicidal behavior at a rate nearly nine times greater than patients given a placebo.
Our cases alleged that Eli Lilly & Company omitted important information about Cymbalta withdrawal risks in the company's labeling and marketing materials, preventing consumers from making informed choices about whether to take Cymbalta.
Declassified court documents obtained by our firm during litigation showed that Eli Lilly was well aware of Cymbalta's withdrawal risks, which occur frequently and can be severe. Instead of disclosing the risk, Lilly hid behind a misleading label, making it appear the risk was rare and the symptoms mild.
This class action lawsuit alleged that Forest Pharmaceuticals engaged in a program of deceptive conduct around pediatric depression treatment. Using a misleading drug label, the "endorsements" of paid opinion leaders, gerrymandered clinical trials, and specially trained sales personnel, Forest misled consumers and the medical community about Celexa's and Lexapro's efficacy in treating pediatric depression.
Documents unearthed during our civil lawsuits revealed that Forest Pharmaceuticals deliberately misled the Department of Justice during its investigation and 2010 settlement. The government's investigation was just the tip of the iceberg—our documents showed much deeper deception than the government ever suspected.
Actos (pioglitazone), manufactured by Takeda Pharmaceuticals USA, is prescribed for blood sugar control in Type 2 Diabetes. Our lawsuits alleged that Actos caused bladder cancer in patients. The documents and court transcripts from this litigation show Takeda misled the FDA and healthcare community regarding Actos' efficacy and safety, hiding harmful side effects that surfaced in clinical trials.
Documents obtained in the discovery phase of litigation revealed that Takeda's US partner, Upjohn, had backed out of the partnership after clinical trials showed the drug posed safety and efficacy risks. The drug was marketed as a safer alternative to Avandia, despite known risks.
This litigation involved Bayer and its company Cutter Laboratories, which manufactured AHF (anti-hemophiliac factor), a blood product used by hemophiliacs to treat uncontrolled bleeding. In the early 1980s, Cutter Laboratories realized that its AHF was contaminated with HIV, but its financial investment in the product was considered too high to destroy the inventory.
Cutter continued to sell the contaminated AHF to markets willing to accept it, including overseas markets in Asia and Latin America, without heat treating the product to eliminate HIV risk. Customers were not informed of the risk, and as a consequence, hemophiliacs who used the HIV-contaminated AHF developed AIDS.
Our firm fought to unseal documents, which revealed the illegal collection of HIV-contaminated plasma from unhealthy donors and the subsequent "dumping" of defective products in international markets, leading to major media investigations, including coverage by The New York Times.
If you or a family member suffered harm from a prescription medication, our pharmaceutical attorneys are here to help. Based in Los Angeles, Wisner Baum represents clients throughout California and across the nation in complex pharmaceutical drug litigation.
Our experienced pharmaceutical attorneys offer:
You don’t have to face Big Pharma alone. Contact our pharmaceutical litigation team today at (310) 207-3233 or complete our online contact form to schedule your free consultation.
With a nationwide reputation as leaders in pharmaceutical litigation, our defective drug lawyers are committed to holding negligent drug companies accountable and helping you secure the compensation you deserve for your injuries.
We have extensive experience litigating drug injury, wrongful death, and consumer class action cases against major pharmaceutical corporations. Our prescription drug attorneys have been at the forefront of pharmaceutical litigation for decades, achieving significant results for our clients.
Our track record in prescription drug litigation includes:
Our pharmaceutical lawyers understand the complex medical and scientific issues involved in prescription drug lawsuits. Wisner Baum has the necessary resources and extensive experience to take on the largest pharmaceutical corporations and achieve successful outcomes.
Prescription medications are meant to improve health conditions and quality of life. But even with FDA approval, it is not uncommon for drugs to cause serious side effects. The consequences of defective drugs can be devastating, ranging from severe health complications to permanent disability or death.
Pharmaceutical litigation is important not only to compensate those harmed by these products, but also to hold drug makers accountable for failing to adequately test products or warn of known or reasonably knowable risks.
A pharmaceutical injury lawsuit typically involves:
For injured patients, a pharmaceutical lawsuit can help pay for medical bills, lost wages, and the pain experienced after taking the medication or receiving a procedure using a defective medical device. Beyond helping individual plaintiffs, pharmaceutical lawsuits help protect all consumers by pushing companies to be honest about their products. These cases often reveal that companies were aware of certain dangers but concealed them to continue generating profits.
When pharmaceutical lawsuits are successful, they not only compensate victims but also compel drug manufacturers to enhance safety standards, update warning labels, and sometimes even remove defective products from the market altogether.
Pharmaceutical drug lawsuits happen when the products cause unexpected harm and the companies that manufacture the products failed to warn about the potential harm. These lawsuits aim to compensate those harmed and hold companies accountable for their negligence or wrongdoing.
To qualify for a drug injury lawsuit, you must have suffered verifiable harm after taking the medication or undergoing a procedure using a defective device. Your lawyer will need to show a clear connection between taking the drug or undergoing a procedure and your injury or side effects.
Most of the time, these lawsuits are consolidated into a mass tort, which is similar to a class action in that many people harmed by the same product join together in front of one judge. The key difference between a mass tort and a class action is that each person's specific injuries and claims for damages differ in a mass tort, so each plaintiff is treated individually. In a class action, the group (“class”) is treated as a single entity with a representative plaintiff (or plaintiffs).
The legal process for prescription drug lawsuits typically takes one to three years, although it can be longer or shorter depending on your case.
Every state has a deadline called a "statute of limitations" for filing these lawsuits, ranging from one to six years after you discover your injury. If you miss this deadline, you may lose your right to seek compensation, so it is crucial to speak to a lawyer as soon as you can about your potential claim.
If you've been harmed by a prescription or over-the-counter medication, an experienced pharmaceutical lawyer can be your strongest advocate.
Our attorneys will:
At Wisner Baum, our California pharmaceutical lawyers handle cases on a contingency fee basis, meaning you pay nothing unless we win your case. This allows anyone harmed by defective drugs to access quality legal representation regardless of their financial situation.
Our pharmaceutical litigation attorneys are currently investigating and accepting cases involving several medications. If any of the following drugs have harmed you, our law firm can help determine if you have a viable claim.
Risperdal (risperidone), Invega (paliperidone), and Zyprexa (olanzapine) are antipsychotic medications linked to an increased risk of breast cancer. Our pharmaceutical lawyers were the first in the country to file a lawsuit alleging Johnson & Johnson and Eli Lilly failed to warn patients and the medical community about the link between antipsychotics and breast cancer, which we allege the companies knew since the 1990s.
Learn more about Antipsychotics and Breast Cancer Lawsuits
Zantac (ranitidine) was a widely used heartburn medication that was found to contain N-nitrosodimethylamine (NDMA), a probable human carcinogen. In 2020, the FDA requested a market withdrawal for Zantac due to these concerns. Our pharmaceutical attorneys are helping individuals who developed cancer after taking Zantac for extended periods.
Learn more about Zantac Cancer Lawsuits
Ozempic (semaglutide) is a popular diabetes and weight loss medication that has been linked to serious adverse effects, including pancreatitis, gallbladder disease, and severe gastrointestinal issues. Our pharmaceutical attorneys are investigating claims for affected patients.
Learn more about Ozempic Lawsuits
Suboxone (buprenorphine/naloxone) is used to treat opioid dependence. It is associated with serious side effects and allegations of anticompetitive practices by its manufacturer. Our law firm represents individuals harmed by this medication.
Learn more about Suboxone Lawsuits
When you work with our California pharmaceutical attorneys, we handle every aspect of your case from start to finish:
The process begins with a free, confidential consultation where our lawyers will review your medical history, drug usage, and resulting injuries to determine if you have a viable claim. We will explain your legal options and what to expect throughout the legal process.
Our pharmaceutical attorneys will collect comprehensive evidence to support your case, including:
Our pharmaceutical lawyers will prepare and file a detailed complaint in the appropriate jurisdiction, whether in state court, federal court, or as part of multidistrict litigation (MDL). The complaint will outline your injuries, the defendant's alleged liability, and the compensation you are seeking.
During discovery, both sides exchange information and evidence. Our pharmaceutical attorneys will depose key witnesses, including company executives and medical experts. We also review internal company documents to determine whether the company engaged in any misconduct related to your claim, and to build the strongest possible case. Our firm is known for getting confidential company documents “unsealed” and publishing important “smoking gun” documents that are important to public health and safety.
Many cases resolve through settlement negotiations. Our law firm will advocate for maximum compensation that fully accounts for your medical expenses, lost income, pain and suffering, and other damages. We will advise you of the strength of any settlement offer, but the final decision to accept remains yours.
If a fair settlement cannot be reached, our pharmaceutical attorneys are fully prepared to take your case to trial. We have extensive courtroom experience and will present compelling evidence and testimony to demonstrate the pharmaceutical company's liability and the extent of your damages.
Each state has a deadline for filing a drug injury lawsuit. In California, the statute of limitations for filing a pharmaceutical lawsuit is generally:
For cases outside California, different timeframes may apply. Additionally, the statute of limitations may be extended through various legal doctrines, including:
To protect your legal rights, it is crucial to consult with a defective drug lawyer as soon as possible after discovering an injury. Our pharmaceutical attorneys can help determine the applicable deadlines in your specific case.
Wisner Baum’s track record of success in pharmaceutical litigation dates back to the 1980s. Our pharmaceutical attorneys have not only won landmark cases against Big Pharma; we have also spearheaded and participated in numerous campaigns to address and correct industry practices that caused our clients to suffer harm. While our efforts may not directly have impacted our casework, we have always fought—and will continue to fight—for safety improvements that have the potential to prevent similar harm from happening in the future.
As managing partner, R. Brent Wisner said in an interview with Super Lawyers Magazine:
"We get these really incredible documents that affect people's public health, and we make a point to get them unsealed. Most lawyers don't bother or care to do that because it doesn't really affect the case; but for us it's a greater good kind of thing."
Lawsuits were filed against Zoloft-maker, Pfizer in the early 2000s alleging the drug caused an increased risk of suicidal behavior, and in the late 2000s, a lawsuit was filed claiming the manufacturer overpromoted the drug’s efficacy.
Internal documents showed Pfizer was aware of Zoloft’s questionable efficacy in treating depression and that the FDA approved the drug despite its efficacy shortcomings only because the FDA’s standard for approving antidepressants is “not as demanding as it ought to be.”
GlaxoSmithKline (GSK) faced hundreds of lawsuits alleging Paxil could induce suicidal behavior in both adults and children/adolescents.
Unsealed internal documents obtained in the litigation showed the Paxil pediatric clinical trials all failed to outperform placebo on primary efficacy measures and that the drug posed a suicidal behavior risk (which GSK misleadingly coded as “emotional lability”) to young people. Nonetheless, the company promoted Paxil as efficacious and denied any suicide risk, using Key Opinion Leaders (KOLs) and ghostwriting positive medical journal articles, contrary to the underlying data.
Documents also showed the company was aware that adult patients given Paxil during clinical trials experienced suicidal behavior at a rate nearly nine times greater than patients given a placebo.
Our cases alleged that Eli Lilly & Company omitted important information about Cymbalta withdrawal risks in the company's labeling and marketing materials, preventing consumers from making informed choices about whether to take Cymbalta.
Declassified court documents obtained by our firm during litigation showed that Eli Lilly was well aware of Cymbalta's withdrawal risks, which occur frequently and can be severe. Instead of disclosing the risk, Lilly hid behind a misleading label, making it appear the risk was rare and the symptoms mild.
This class action lawsuit alleged that Forest Pharmaceuticals engaged in a program of deceptive conduct around pediatric depression treatment. Using a misleading drug label, the "endorsements" of paid opinion leaders, gerrymandered clinical trials, and specially trained sales personnel, Forest misled consumers and the medical community about Celexa's and Lexapro's efficacy in treating pediatric depression.
Documents unearthed during our civil lawsuits revealed that Forest Pharmaceuticals deliberately misled the Department of Justice during its investigation and 2010 settlement. The government's investigation was just the tip of the iceberg—our documents showed much deeper deception than the government ever suspected.
Actos (pioglitazone), manufactured by Takeda Pharmaceuticals USA, is prescribed for blood sugar control in Type 2 Diabetes. Our lawsuits alleged that Actos caused bladder cancer in patients. The documents and court transcripts from this litigation show Takeda misled the FDA and healthcare community regarding Actos' efficacy and safety, hiding harmful side effects that surfaced in clinical trials.
Documents obtained in the discovery phase of litigation revealed that Takeda's US partner, Upjohn, had backed out of the partnership after clinical trials showed the drug posed safety and efficacy risks. The drug was marketed as a safer alternative to Avandia, despite known risks.
This litigation involved Bayer and its company Cutter Laboratories, which manufactured AHF (anti-hemophiliac factor), a blood product used by hemophiliacs to treat uncontrolled bleeding. In the early 1980s, Cutter Laboratories realized that its AHF was contaminated with HIV, but its financial investment in the product was considered too high to destroy the inventory.
Cutter continued to sell the contaminated AHF to markets willing to accept it, including overseas markets in Asia and Latin America, without heat treating the product to eliminate HIV risk. Customers were not informed of the risk, and as a consequence, hemophiliacs who used the HIV-contaminated AHF developed AIDS.
Our firm fought to unseal documents, which revealed the illegal collection of HIV-contaminated plasma from unhealthy donors and the subsequent "dumping" of defective products in international markets, leading to major media investigations, including coverage by The New York Times.
If you or a family member suffered harm from a prescription medication, our pharmaceutical attorneys are here to help. Based in Los Angeles, Wisner Baum represents clients throughout California and across the nation in complex pharmaceutical drug litigation.
Our experienced pharmaceutical attorneys offer:
You don’t have to face Big Pharma alone. Contact our pharmaceutical litigation team today at (310) 207-3233 or complete our online contact form to schedule your free consultation.
With a nationwide reputation as leaders in pharmaceutical litigation, our defective drug lawyers are committed to holding negligent drug companies accountable and helping you secure the compensation you deserve for your injuries.
Yes. We are a California-based law firm, but our team of pharmaceutical drug lawyers represents clients across all 50 states. We have offices in Los Angeles, the San Francisco Bay Area, and Washington D.C.
Yes, you may be able to sue for drug side effects if you suffered serious harm that was not properly disclosed, or if the medication was defectively designed, manufactured, or marketed. Many states allow patients to take legal action against pharmaceutical companies when side effects cause significant injuries—especially if the company failed to provide adequate warnings, misrepresented the drug’s safety, or sold a defective product.
To have a valid lawsuit, you generally need to show:
Drug side effect claims can be brought individually or as part of a larger group (mass tort). Taking action as soon as you are able is important because strict legal deadlines (statutes of limitations) apply. An experienced drug injury attorney can review your circumstances, explain your options, and help you pursue compensation for medical bills, lost wages, pain and suffering, and more
Most pharmaceutical attorneys—including our team—work on a contingency fee basis, which means you pay nothing upfront and owe no legal fees unless we win compensation for you through a settlement or verdict. Your initial consultation is always free. If we take your case, our firm advances all legal expenses—including expert witnesses, medical reviews, and court costs—so you never have to pay anything out-of-pocket. Our fee is simply a percentage of the compensation we recover for you, agreed upon before representation begins.
If we don’t recover money for you, you owe us nothing.
You may have a basis to file a drug lawsuit if you took a prescription medication as directed and developed a serious side effect or injury or the manufacturer did not adequately warn about the potential risks, and you required medical treatment as a result. The timing between taking the medication and developing symptoms is also important. Our pharmaceutical drug lawyers can evaluate your specific situation during a free consultation to determine if you have a viable claim.
Yes. FDA approval doesn't shield pharmaceutical companies from liability. Drug manufacturers have an ongoing duty to monitor the safety of their products and update warnings as new risks are identified. If a company fails to adequately warn about risks, conceals information from the FDA, or engages in deceptive marketing practices, it can be held liable regardless of FDA approval.
Multiple parties may be liable in pharmaceutical litigation, including drug manufacturers, distributors, marketing companies, testing laboratories, and, in some cases, healthcare providers who prescribe the medication despite known contraindications. Our pharmaceutical attorneys will identify all potentially responsible parties in your case.
In a pharmaceutical lawsuit, you pursue compensation for your specific injuries, with your case evaluated based on your unique circumstances and damages. In some cases, your case will be consolidated into a federal multidistrict litigation (MDL) or a state court variant. While an MDL shares similarities to a class action, it is notably different in a few important ways.
In a class action, a representative plaintiff brings a case on behalf of many people with similar claims, with any settlement distributed among all class members. Mass tort litigation (such as multidistrict litigation or MDL) combines aspects of both approaches, with cases consolidated for efficiency while each plaintiff's injuries and compensation are evaluated individually.
The timeline for pharmaceutical litigation varies widely depending on factors such as the complexity of the medical issues, the number of plaintiffs, the strength of scientific evidence, whether the case is part of multidistrict litigation, and the defendant's willingness to settle.
Some cases resolve within 1-2 years, but these are the exception, not the rule. Complex pharmaceutical litigation may take several years. Our drug injury lawyers work efficiently to resolve your case as quickly as possible while still pursuing maximum compensation.
Compensation in pharmaceutical litigation may include:
The specific damages available depend on your particular circumstances, the severity of your injuries, and applicable state laws.
If you suspect a medication has caused you harm:
Possibly. Even if a side effect was mentioned on the label, you may have a case if the warning was not sufficiently prominent or clear, understated the risk or severity, was added after you suffered harm, or if the drug was marketed in a way that downplayed the warnings. Our pharmaceutical attorneys can evaluate whether the warnings were legally adequate in your specific case.
If multiple medications potentially contributed to your injury, our lawyers will work with medical experts to determine which drug or combination of drugs was responsible. We may pursue claims against multiple pharmaceutical companies if appropriate. The complex nature of these cases highlights the importance of working with attorneys experienced in pharmaceutical litigation.
